| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/05/2003 | EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1202984B1 diphenyl-piperidine derivate |
| 03/05/2003 | EP1194427B1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
| 03/05/2003 | EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/05/2003 | EP1021411B1 Benzamide derivatives as thrombin inhibitors |
| 03/05/2003 | EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
| 03/05/2003 | EP0832069B1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| 03/05/2003 | CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/05/2003 | CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound |
| 03/05/2003 | CN1102583C Cationic polypeptide condensing agent of thiazole,its synthesizing process and its application |
| 03/05/2003 | CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same |
| 03/05/2003 | CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid |
| 03/04/2003 | US6528510 HIV protease inhibitors |
| 03/04/2003 | US6528509 Pyrazole compositions useful as inhibitors of ERK |
| 03/04/2003 | CA2218913C Substituted oximes, hydrazones and olefins as neurokinin antagonists |
| 02/27/2003 | WO2003016306A1 Hiv inhibiting pyrimidines derivatives |
| 02/27/2003 | WO2003016303A1 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016286A1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
| 02/27/2003 | WO2003016284A1 Substituted anthranilamides for controlling invertebrate pests |
| 02/27/2003 | WO2003016276A2 3-substituted oxindole beta-3 agonists |
| 02/27/2003 | WO2003016275A1 Antiviral agent |
| 02/27/2003 | WO2003016265A1 Cyclic compound and ppar agonist |
| 02/27/2003 | WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | WO2003015778A1 Tyrosine kinase inhibitors |
| 02/27/2003 | WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/27/2003 | WO2003015774A1 Compounds effecting glucokinase |
| 02/27/2003 | WO2003015773A2 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
| 02/27/2003 | WO2003015772A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | WO2003015769A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | WO2003015717A2 Tyrosine kinase inhibitors |
| 02/27/2003 | WO2002100851A3 Thiophene derivatives as antiviral agents for flavivirus infection |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2002089782A3 Dioxanes and uses thereof |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002079149A3 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 02/27/2003 | WO2002074042A3 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 02/27/2003 | WO2002067869A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/27/2003 | WO2002067675A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides |
| 02/27/2003 | WO2002060904A3 A process for the preparation of epothilone analogs |
| 02/27/2003 | WO2002060374A3 Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
| 02/27/2003 | US20030040631 As chemical intermediates used for the preparation of S-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 02/27/2003 | US20030040608 Having good hue and capable of forming images having high lightfastness |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040524 Pyrimidine compounds and methods for making and using the same |
| 02/27/2003 | US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons |
| 02/27/2003 | US20030040513 P2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 02/27/2003 | CA2457037A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 02/27/2003 | CA2456985A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | CA2456868A1 Inhibitors of polyq-aggregation |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/26/2003 | EP1285918A1 C7 Ester substituted taxanes as antitumor agents |
| 02/26/2003 | EP1285653A1 Use of alpha-1L agonists in the treatment of incontinence |
| 02/26/2003 | EP1285651A1 Melanin concentrating hormone antagonists |
| 02/26/2003 | EP1284970A2 Isothiazole derivatives and their use as microbicides |
| 02/26/2003 | EP1284967A1 3-substituted isoquinolin-1-yl derivatives |
| 02/26/2003 | EP1284737A1 Water soluble prodrugs of azole compounds |
| 02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/26/2003 | EP1021424B1 Thiadiazole amide mmp inhibitors |
| 02/26/2003 | EP0971901B1 Phthalazinones |
| 02/26/2003 | CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399515A Insecticidal and acaricidal agents |
| 02/26/2003 | CN1102149C 4-haloalkyl-3-heterocycolyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 02/25/2003 | US6525220 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 02/25/2003 | US6525193 Aminoaryl oxazolidinone N-oxides |
| 02/25/2003 | US6525081 Antirheumatic |
| 02/25/2003 | US6525076 Selective factor Xa inhibitors |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases |
| 02/25/2003 | US6525059 Substituted pyrazoles as p38 kinase inhibitors |
| 02/25/2003 | US6525052 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/20/2003 | WO2003014095A1 Acylaminothiazole derivatives, their preparation and therapeutic use |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | WO2003013571A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | WO2003013531A1 Phenyl derivatives as factor xa inhibitors |
| 02/20/2003 | WO2003013518A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 02/20/2003 | WO2003013517A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/20/2003 | WO2003013502A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002085291A3 Nociceptin analogs |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2001079187A8 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/20/2003 | US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/20/2003 | US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus |
| 02/20/2003 | US20030036544 Pesticidal triazine-derivatives |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2462200A1 Peptidomimetics of biologically active metallopeptides |
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | CA2456553A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 02/20/2003 | CA2455631A1 Aminoisoxazole derivatives active as kinase inhibitors |
| 02/19/2003 | EP1284268A1 Thiazolidinedione derivative and its use as antidiabetic |
| 02/19/2003 | EP1284267A1 Triazole compounds having amide linkage |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |